Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Mega Matrix	MPU	15. nov 2024	1.62	-4.71
Megacap 300 Growth Index ETF Vanguard	MGK	15. nov 2024	331.20	-2.16
Megacap 300 Index ETF Vanguard	MGC	15. nov 2024	210.88	-1.51
Megacap 300 Value Index ETF Vanguard	MGV	15. nov 2024	129.59	-0.38
MEI Pharma	MEIP	15. nov 2024	2.92	-2.99
Meihua International Medical Technologies	MHUA	15. nov 2024	0.47	-5.39
MeiraGTx Holdings	MGTX	15. nov 2024	6.48	-2.41
Meiwu Technology	WNW	15. nov 2024	0.85	+6.38
Melar Acquisition I	MACI	15. nov 2024	10.03	-0.20
Melar Acquisition I	MACIU	15. nov 2024	10.13	0.00
Melco Resorts & Entertainment ADR	MLCO	15. nov 2024	6.12	-0.97
MercadoLibre	MELI	15. nov 2024	1 880.00	+0.20
Mercantile Bank	MBWM	15. nov 2024	49.10	-0.71
Mercer International	MERC	15. nov 2024	6.20	-2.36
Merchants Bancorp	MBIN	15. nov 2024	40.19	-0.45
Merchants Bancorp B	MBINO	15. nov 2024	25.36	+0.07
Merchants Bancorp C Pref	MBINN	15. nov 2024	22.69	-0.04
Merchants Bancorp Pref D	MBINM	15. nov 2024	26.42	-0.90
Merck & Co	MRK	15. nov 2024	96.31	-2.08
Mercurity Fintech	MFH	15. nov 2024	3.78	+5.88
Mercury General	MCY	15. nov 2024	73.00	-0.55
Mercury Systems	MRCY	15. nov 2024	39.32	-3.72
Mereo BioPharma ADR	MREO	15. nov 2024	3.53	-7.59
Meridian	MRBK	15. nov 2024	14.23	+0.57
MeridianLink	MLNK	15. nov 2024	22.02	-3.00
Merit Medical Systems	MMSI	15. nov 2024	101.83	+0.62
Meritage Homes	MTH	15. nov 2024	179.41	-1.00
Merrill Lynch & Co.	IPB	15. nov 2024	26.20	+0.38
Mersana Therapeutics	MRSN	15. nov 2024	2.21	-12.30
Merus N.V	MRUS	15. nov 2024	46.58	-6.20

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.